On Demand Webinars
Challenging Standards for Genetic Characterization of Manufacturing Cell Lines
Presented by Jurgen Mullberg, Expert for Development of Mammalian Cell Lines and Therapeutic Proteins, formerly Associate Director – Cell Substrate & Viral Safety at Bristol Myers Squibb
14th November 2025
Potency Assays and Functional Characterisation – Going Hand-in-Hand during Product Development up to Commercial Licensing
Presented by Therese Choquette, PhD. Head of Analytical and Translational Sciences at Tigen Pharma, Ulrike Herbrand, Scientific Director Global in vitro Bioassays and Head of the Bioassay Research & Development team at Charles River Laboratories and Felix Montero Julian, Vice President of Scientific Affairs at Accellix
13th November 2025
Oncolytic Virus GMP Manufacturing: Solving Antibody Neutralization Challenges with Next Generation Sequencing
Presented by Colette Côté, PhD, U.S. General Manager and Chief Scientific and Portfolio Officer at PathoQuest
12th November 2025
Drive Efficiency With Pre-engineered Solutions for Industrial Automation
Presented by Scott Mangiacotti, Sr. Director, Automation Solutions at Cytiva
06th November 2025
Navigating mRNA Impurities: A Focus on Quality
Presented by Sarita Kattel, M.S, Principal Scientist, Global Biologics at US Pharmacopeia, Melisa Wilson, M.S, Director, Blazar and mRNA QC R&D programs at Merck and Jeremy Schofield, PhD. Senior Scientist, Blazar and mRNA QC R&D program at Merck
04th November 2025
A Digital-First Approach to Downstream Bioprocessing
Presented by Laura Pereira Diaz, In Silico First Program & Strategy Manager at Takeda
03rd November 2025
Risk Assessment and Mitigation Strategies for Production Cell Substrates
Presented by Jürgen Hubert Blusch, Consultant - Ex-Novartis Senior Expert Cell Line Analytics and Adventitious Agents
29th October 2025
Effective Extractable & Leachable Study Design
Presented by Divya Regulagedda, Manager, Global SME- Extractables & Leachables at Chemo
08th October 2025
Just in Time Release of CAR T Cell Therapies
Presented by Irving Ford, Quality Executive who was previously at Adaptimmune, and Owen Griffin, Senior Director, Microbiology at Rapid Micro Biosystems
03rd October 2025
Analytical Assessment of Leachables in Biological Drug Products: FDA Approach in Reviewing Information
Presented by Andrey Sarafanov; PhD., Principal Investigator at U.S. FDA, Center for Biologics Evaluation and Research, Molly Haan, Senior Technical Customer Support Scientist at NAMSA , James Hathcock, Sr. Director, Regulatory and Validation Strategy at Cytiva
02nd October 2025
